Waeber C, Rigo M, Chinaglia G, Probst A, Palacios J M
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.
Synapse. 1991 Aug;8(4):270-80. doi: 10.1002/syn.890080405.
The density of [125I]iodo-cyanopindolol binding to beta-1 and beta-2 adrenergic receptors was studied in post mortem basal ganglia samples of Huntington's chorea and Parkinson's disease patients using autoradiography. Whereas no significant changes were observed in sections from Parkinson's and Huntington's chorea grade 2 patients, a nearly complete loss of beta-1 binding sites was observed in the basal ganglia of Huntington patients at later stages of the disease. The concentration of beta-2 receptors was increased by a factor 2 in the posterior putamen of all choreic cases. These results are consistent with the view that beta-1 receptors are predominantly located on a subpopulation of neurons which degenerate at late stages of Huntington's chorea, while beta-2 receptors are present mainly on glial elements.
利用放射自显影技术,研究了亨廷顿舞蹈症和帕金森病患者死后基底神经节样本中[125I]碘氰吲哚洛尔与β-1和β-2肾上腺素能受体结合的密度。帕金森病患者和亨廷顿舞蹈症2级患者的切片未观察到显著变化,而在疾病后期的亨廷顿舞蹈症患者基底神经节中,观察到β-1结合位点几乎完全丧失。在所有舞蹈症病例的后壳核中,β-2受体浓度增加了2倍。这些结果与以下观点一致,即β-1受体主要位于亨廷顿舞蹈症晚期退化的神经元亚群上,而β-2受体主要存在于神经胶质细胞上。